Physical and functional interaction between HCV core protein and the different p73 isoforms

被引:51
作者
Alisi, A
Giambartolomei, S
Cupelli, F
Merlo, P
Fontemaggi, G
Spaziani, A
Balsano, C
机构
[1] Fdn Andrea Cesalpino, Med Clin 1, I-00161 Rome, Italy
[2] Univ Aquila, Dip MISP, I-67100 Laquila, Italy
[3] Regina Elena Inst Canc Res, I-00158 Rome, Italy
关键词
HCV; core p53; p73; p21(WAF1/CIP1); HCC;
D O I
10.1038/sj.onc.1206333
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatitis C virus (HCV) core protein is a structural viral protein that packages the viral genomic RNA. In addition to this function, HCV core also modulates a number of cellular regulatory functions. In fact, HCV core protein has been found to modulate the expression of the cyclin-dependent inhibitor p21(WAF1/CIP1) and to promote both apoptosis and cell proliferation through its physical interaction with p53. Here, we studied the ability of HCV core to bind the p53-related p73 protein, its isoforms and its deletion mutants. We found that HCV core co-immunoprecipitated with p73 in HepG2 and SAOS-2 cells. Deletion mutational analysis of p73 indicates that the domain involved in HCV core binding is located between amino-acid residues 321-353. We also demonstrate that p73/core interaction results in the nuclear translocation of HCV core protein either in the presence of the p73 or or p73 beta tumor-suppressor proteins. In addition, the interaction with HCV core protein prevents p73 alpha, but not p73 beta dependent cell growth arrest in a p53-dependent manner. Our findings demonstrate that HCV core protein may directly influence the various p73 functions, thus playing a role in HCV pathogenesis.
引用
收藏
页码:2573 / 2580
页数:8
相关论文
共 45 条
[31]   CDK inhibitors:: positive and negative regulators of G1-phase progression [J].
Sherr, CJ ;
Roberts, JM .
GENES & DEVELOPMENT, 1999, 13 (12) :1501-1512
[32]   Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins [J].
Shi, ST ;
Polyak, SJ ;
Tu, H ;
Taylor, DR ;
Gretch, DR ;
Lai, MMC .
VIROLOGY, 2002, 292 (02) :198-210
[33]   Transactivation-deficient △TA-p73 inhibits p53 by direct competition for DNA binding -: Implications for tumorigenesis [J].
Stiewe, T ;
Theseling, CC ;
Pützer, BM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (16) :14177-14185
[34]  
Takamatsu Manabu, 2001, Kobe Journal of Medical Sciences, V47, P97
[35]  
TANNAPFEL A, 1999, J NATL CANCER I, V79, P164
[36]   The many roles of c-Myc in apoptosis [J].
Thompson, EB .
ANNUAL REVIEW OF PHYSIOLOGY, 1998, 60 :575-600
[37]   Interaction of hepatitis C virus core protein with retinoid X receptor α modulates its transcriptional activity [J].
Tsutsumi, T ;
Suzuki, T ;
Shimoike, T ;
Suzuki, R ;
Moriya, K ;
Shintani, Y ;
Fujie, H ;
Matsuura, Y ;
Koike, K ;
Miyamura, T .
HEPATOLOGY, 2002, 35 (04) :937-946
[38]   Hepatitis C virus core protein binds to a C-terminal region of NS5B RNA polymerase [J].
Uchida, M ;
Hino, N ;
Yamanaka, T ;
Fukushima, H ;
Imanishi, T ;
Uchiyama, Y ;
Kodama, T ;
Doi, T .
HEPATOLOGY RESEARCH, 2002, 22 (04) :297-306
[39]   DN-p73 is activated after DNA damage in a p53-dependent manner to regulate p53-induced cell cycle arrest [J].
Vossio, S ;
Palescandolo, E ;
Pediconi, N ;
Moretti, F ;
Balsano, C ;
Levrero, M ;
Costanzo, A .
ONCOGENE, 2002, 21 (23) :3796-3803
[40]   E1B 55-kilodalton oncoproteins of adenovirus types 5 and 12 inactivate and relocalize p53, but not p51 or p73, and cooperate with E4orf6 proteins to destabilize p53 [J].
Wienzek, S ;
Roth, J ;
Dobbelstein, M .
JOURNAL OF VIROLOGY, 2000, 74 (01) :193-202